# 2025-23413: FDA Zaps Tongue Nerve Stimulators into Moderate Regulation Category

2025-23413, Medical Devices; Neurological Devices; Classification of the Electrical Tongue Nerve Stimulator To Treat Motor Deficits, is a Federal Register rule from Health and Human Services Department, Food and Drug Administration published 2025-12-19, effective 2025-12-19 (as of 2026-06-11).

- Canonical: https://policyrisk.com/federal-register/2025-23413
- As of: 2026-06-11
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-23413
- Title: Medical Devices; Neurological Devices; Classification of the Electrical Tongue Nerve Stimulator To Treat Motor Deficits
- Type: Rule
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 59377
- Published: 2025-12-19
- Effective: 2025-12-19
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-11

## In one line

FDA Zaps Tongue Nerve Stimulators into Moderate Regulation Category

## Summary

The FDA is officially classifying the electrical tongue nerve stimulator, a device that helps people with movement problems, as a Class II device with special safety rules. This change makes it easier and faster for patients to get this innovative treatment by reducing some regulatory hurdles. The new classification is effective December 19, 2025, and could speed up device availability without extra costs for users.

## Abstract

The Food and Drug Administration (FDA, the Agency, or we) is classifying the electrical tongue nerve stimulator to treat motor deficits into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the classification of the electrical tongue nerve stimulator to treat motor deficits. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

## Effects PRIA read

- Class II ruling speeds patient access: benefit, medium. The FDA classified the electrical tongue nerve stimulator as a Class II device with special controls, which the agency says will enhance patients' access and reduce regulatory burdens. The final order is effective December 19, 2025, and FDA states this classification can make it easier and faster f…
- Creates predicate for future devices: benefit, medium. Because FDA classified this device via the De Novo process, the electrical tongue nerve stimulator can serve as a predicate device. Future device sponsors can use the less-burdensome 510(k) process instead of a De Novo request or premarket approval, lowering regulatory hurdles for companies making…
- Manufacturers must meet special controls: cost, medium. To be classified as Class II, manufacturers must meet special controls including biocompatibility testing for patient-contacting components; electromagnetic, battery, electrical, mechanical, and thermal safety testing; non-clinical performance testing of stimulation parameters; software verificatio…
- Device is prescription-only: cost, low. The FDA states the electrical tongue nerve stimulator is a prescription device. That means the device is available only with a prescription and is exempt from layperson 'adequate directions for use' requirements under specified statutory provisions.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-23413 on federalregister.gov](https://www.federalregister.gov/documents/2025/12/19/2025-23413/medical-devices-neurological-devices-classification-of-the-electrical-tongue-nerve-stimulator-to)
- [2025-23413 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-12-19/pdf/2025-23413.pdf)

## Related
- [Previous: 2025-23412, Safety Zone; Fireworks Display, Ohio River Mile Marker 73 to 74, Wellsburg, WV](https://policyrisk.com/federal-register/2025-23412)
- [Next: 2025-23414, Falsification, Reproduction, Alteration, Omission, or Incorrect Statements](https://policyrisk.com/federal-register/2025-23414)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-23413 (as of 2026-06-11).
